BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Policy

  Neovasc Announces Receipt of German NUB Status 1 Designation for Neovasc Reducer Procedure for Treatment of Refractory Angina

  InEK, is responsible for prioritizing new therapies in Germany through the NUB process.

  February 1, 2018

   · 

  8 min read
• Pharm Country

  Schrödinger Announces Cryo-EM Initiative

  SCI utilizes a network of Cryo-EM centers including the New York Structural Biology Center, Stanford University, and China’s Tsinghua University, with anticipated expansion to include additional institutions.

  February 1, 2018

   · 

  3 min read
• Pharm Country

  CytoSorbents’ New Study Demonstrates Improved Hemodynamic Stability After Heart Transplant Surgery Using Intraoperative CytoSorb Blood Purification

  CytoSorbents highlights the recent publication entitled, “Impact of intraoperative cytokine adsorption on outcome of patients undergoing orthotopic heart transplantation - an observational study” in the medical journal Clinical Transplantation

  February 1, 2018

   · 

  7 min read
• Business

  PharmAbcine Enters Collaboration with MSD Focused on Clinical Evaluation of TTAC-0001 in Combination with KEYTRUDA® (pembrolizumab) in Recurrent Glioblastoma and Breast Cancer

  PharmAbcine’s lead candidate TTAC-0001, an investigational therapy, is a highly selective and potent anti-VEGFR2 (KDR/flk-1) mAb in clinical development for rGBM indications.

  February 1, 2018

   · 

  4 min read
• 

  Deals

  Teva Wraps Up $703M Sale of Global Women’s Health Biz to CVC Capital

  The portfolio includes Ovaleap, Zoely, Seasonique, Colpotrophine, Actonel and additional products.

  February 1, 2018

   · 

  5 min read
• Business

  Rubius Therapeutics Appoints Francis Cuss and Catherine Sohn to Board of Directors

  Rubius Therapeutics today announced the appointments of Francis Cuss, MB, MChir, FRCP and Catherine Sohn, Pharm.D., to its board of directors.

  February 1, 2018

   · 

  4 min read
• Business

  Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2017 Financial Results

  Alnylam announced today that it will report financial results for the fourth quarter and year ending December 31, 2017 on Thursday, February 8, 2018, before the U.S. financial markets open.

  February 1, 2018

   · 

  2 min read
• 

  Genetown

  Cambridge’s AVROBIO Lands $60M to Push Fabry, Rest of Pipeline Into the Clinic

  The company plans to initiate a Phase 2 clinical trial this year with AVR-RD-01 in Fabry disease.

  February 1, 2018

   · 

  5 min read
• Business

  McKesson Reports Fiscal 2018 Third-Quarter Results

  McKesson today reported that revenues for the third quarter ended December 31, 2017, were $53.6 billion, up 7% compared to $50.1 billion a year ago.

  February 1, 2018

   · 

  50 min read
• Business

  Baxter Reports 2017 Fourth-Quarter and Full-Year Results

  Baxter International, Inc. today reported results for the fourth quarter and full-year ended December 31, 2017, and provided its financial guidance for 2018.

  February 1, 2018

   · 

  33 min read